Owens & Minor (OMI)

Owens & Minor, Inc. is a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services to deliver significant and sustained value across the breadth of the industry – from acute care to patients in their home. Aligned to its Mission of Empowering Its Customers to Advance HealthcareTM, more than 15,000 global teammates serve over 4,000 healthcare industry customers. A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products. This seamless value chain integrates with a portfolio of products representing 1,200 branded suppliers. Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America.

Company profile

Edward Pesicka
Fiscal year end
Former names
Owens & Minor Distribution, Inc. • Owens & Minor Medical, Inc. • Barista Acquisition I, LLC • Barista Acquisition II, LLC • O&M Halyard, Inc. • Byram Holdings • Byram Healthcare Centers, Inc. • Owens & Minor International • 500 Expressway Drive South LLC • Access Diabetic Supply, L.L.C. ...
IRS number

OMI stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
Low target
High target
4 Aug 22
Credit Suisse
4 Aug 22


3 Aug 22
13 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 73.03M 73.03M 73.03M 73.03M 73.03M 73.03M
Cash burn (monthly) 51.66M (no burn) (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 75.28M n/a n/a n/a n/a n/a
Cash remaining -2.25M n/a n/a n/a n/a n/a
Runway (months of cash) -0.0 n/a n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
15 Jul 22 Robert J Henkel Common Stock Buy Acquire P No Yes 31.76 1,000 31.76K 27,000
12 Jul 22 Carissa Rollins Common Stock Grant Acquire A No No 0 4,490 0 4,490
11 Jul 22 Tammy L Gomez Common Stock Grant Acquire A No No 0 15,904 0 15,904
13F holders Current Prev Q Change
Total holders 263 273 -3.7%
Opened positions 34 59 -42.4%
Closed positions 44 32 +37.5%
Increased positions 87 63 +38.1%
Reduced positions 102 117 -12.8%
13F shares Current Prev Q Change
Total value 3.38B 3.15B +7.5%
Total shares 76.72M 72.2M +6.3%
Total puts 248.1K 1.93M -87.1%
Total calls 221.4K 315K -29.7%
Total put/call ratio 1.1 6.1 -81.7%
Largest owners Shares Value Change
BLK Blackrock 11.9M $523.7M +1.4%
FMR 9.96M $438.54M +193.3%
Vanguard 8.07M $355.18M +0.8%
Wellington Management 7.55M $332.48M +1.0%
Dimensional Fund Advisors 3.31M $145.65M -4.9%
STT State Street 2.73M $120.19M +3.5%
William Blair Investment Management 2.63M $115.94M +26.1%
Allspring Global Investments 2.23M $98.25M -22.3%
Brown Advisory 1.55M $68.14M +8.2%
Renaissance Technologies 1.53M $67.35M -6.7%
Largest transactions Shares Bought/sold Change
FMR 9.96M +6.57M +193.3%
Citadel Advisors 40.62K -1.28M -96.9%
Allspring Global Investments 2.23M -640.86K -22.3%
William Blair Investment Management 2.63M +544.57K +26.1%
Ceredex Value Advisors 741.57K -528.4K -41.6%
Alyeska Investment 465.31K +465.31K NEW
Allianz Asset Management GmbH 702.89K +455.19K +183.8%
Millennium Management 400.4K -359.72K -47.3%
BAC Bank Of America 648.6K +324.96K +100.4%
Norges Bank 0 -306.16K EXIT

Financial report summary

  • Our operating income is dependent on certain significant domestic suppliers.
  • An interruption in the ability of our business to manufacture products may have a material adverse effect on our business.
  • An inability to obtain key components, raw materials or manufactured products from third parties may have a material adverse effect on our business.
  • Our Global Products segment is exposed to price fluctuations of key commodities, which may negatively impact our results of operations.
  • Our business and operations depend on the proper functioning of critical facilities, supply chain and distribution networks.
  • Interruption of our supply chain could affect our ability to produce or distribute our products and could negatively impact our business and profitability.
  • Our profitability and cash flow may vary based on the impacts of rising inflationary pressures.
  • Our operations depend on the proper functioning of information systems, and our business or results of operations could be adversely affected if we experience a cyberattack or other systems breach or failure.
  • Our ability to attract and retain talented and qualified teammates is critical to our success and competitiveness.
  • We have concentration in and dependence on certain healthcare provider customers and Group Purchasing Organizations.
  • We cannot assure you that the proposed Apria Acquisition will be completed.
  • We may fail to realize the anticipated benefits of the Apria Acquisition or those benefits may take longer to realize than expected. We may also encounter significant difficulties in integrating the Apria business into our operations.
  • We and the Apria business will be subject to business uncertainties while the Apria Acquisition is pending that could adversely affect our business and the Apria business.
  • The pendency of the Apria Acquisition could adversely affect our business, financial results, and operations.
  • Our results of operations may suffer upon the bankruptcy, insolvency, or other credit failure of a customer that has a substantial amount owed to us.
  • We are subject to stringent regulatory and licensing requirements.
  • We must obtain clearance or approval from the appropriate regulatory authorities prior to introducing a new product or a modification to an existing product. The regulatory clearance process may result in substantial costs, delays and limitations on the types and uses of products we can bring to market, any of which could have a material adverse effect on our business.
  • Our business may be adversely affected if we are unable to adequately establish, maintain, protect and enforce our intellectual property and proprietary rights or prevent third parties from making unauthorized use of such rights.
  • We may become subject to litigation brought by third parties claiming infringement, misappropriation or other violation by us of their intellectual property rights.
  • We may incur product liability losses, litigation liability, product recalls, safety alerts or regulatory action associated with the products that we source, assemble, manufacture and sell which can be costly and disruptive to our business.
  • Audits by tax authorities could result in additional tax payments for prior periods, and tax legislation could materially adversely affect our financial results and tax liabilities.
  • We may not be able to generate sufficient cash to service our debt and other obligations.
  • We may not be able to refinance, extend or repay our substantial indebtedness which would have a material adverse affect on our financial condition.
  • Despite current indebtedness levels, we will incur substantially more debt to complete the acquisition of Apria, Inc. (Apria Acquisition) which could further exacerbate the risks described herein.
  • Our variable rate indebtedness subjects us to interest rate risk, which could cause our indebtedness service obligations to increase significantly.
  • Our credit facilities and our existing notes have restrictive covenants that could limit our financial flexibility.
  • General economic conditions may adversely affect demand for our products and services.
  • Changing conditions in the United States healthcare industry may impact our results of operations.
  • Our continued success is substantially dependent on positive perceptions of our reputation.
  • Our goodwill may become impaired, which would require us to record a significant charge to earnings in accordance with generally accepted accounting principles.
  • We may be adversely affected by global climate change or by legal, regulatory or market responses to such change.
Management Discussion
  • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  • related notes thereto, and management’s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the year ended December 31, 2021.
  • Owens & Minor, Inc., along with its subsidiaries, (we, us, or our) is a leading global healthcare solutions company. To better reflect how we go to market as well as certain changes to the leadership team, organizational structure, budgeting and financial reporting processes, we have organized our business into two distinct segments: Products & Healthcare Services and Patient Direct. Products & Healthcare Services provides distribution, outsourced logistics and value-added services, and manufactures and sources medical surgical products through our production and kitting operations. Patient Direct expands our business along the continuum of care through delivery of disposable medical supplies sold directly to patients and home health agencies and is a leading provider of integrated home healthcare equipment and related services in the United States. Beginning with the quarter ended March 31, 2022, we now report financial results using this two segment structure and have recast prior year segment results on the same basis.

Content analysis

H.S. sophomore Avg
New words: accrual, cancellable, commitment, computed, computing, created, entitled, excellence, implicit, inflation, leasehold, macroeconomic, method, Morgantown, noncancelable, noncancellable, point, prepaid, proportional, remitted, rental, shorter, site, Virginia, West
Removed: board, charitable, decreased, defense, Department, European, force, granted, Human, life, national, partial, payment, recovery, reputation, shift, support, teammate, travel